Dianthus Therapeutics, Inc.: cash_and_equivalents
| Value | {"amount": 36881000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2022-09-30) |
| Status | current |
| Entity | Dianthus Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:19:32.661739+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/9b508e72-e91c-4b65-88fa-4f9089c8bc99
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-23-062070 · Open the official SEC filing →Retrieved: 2026-08-19T17:19:32.661739+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001690585/cash-and-equivalents/2022-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/9b508e72-e91c-4b65-88fa-4f9089c8bc99
History
- supersedes {"amount": 59028000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} (evidence 0000950170-22-021603)